Dr. Pratibha Dhiman is a Senior Consultant Hematologist specializing in Bone Marrow Transplant (BMT) and Hemato-Oncology at Max Super Speciality Hospital, Dwarka. She has extensive expertise in stem cell transplants, acute and chronic leukemias, GVHD therapies, bone marrow failure syndromes, and innovative immunotherapies. She is recognized for her pioneering work in Extracorporeal Photopheresis (ECP) therapy for Cutaneous T-cell Lymphoma in India and has significantly contributed to advancing hematology programs.

Dr. Pratibha Dhiman has held key positions at Medanta Hospital in Gurugram, HCG Cancer Centre in Vadodara, and Geetanjali Medical College in Udaipur. She completed her DM in Clinical Hematology at Medical College, Kolkata, and a fellowship in Leukemia and BMT at Vancouver General Hospital. She trained at Oxford University and PGIMS Rohtak. She launched the BMT unit at HCG Vadodara, has multiple research publications, and received the ISTH Reach the World Grant, evidencing her remarkable contributions to hematology.

A hematologist in New Delhi specializing in stem cell transplants evaluates patients who may benefit from this therapy, particularly those with certain hematologic malignancies and non-malignant hematological disorders. They oversee the collection of stem cells, manage the transplantation process, and closely monitor patients post-transplant to ensure the new stem cells engraft properly, reducing complications and optimizing recovery.

A hematologist in New Delhi diagnoses and treats both acute and chronic leukemias by evaluating the type and progression of the disease. Treatment may include chemotherapy, targeted therapy, and, in some cases, stem cell transplantation. The hematologist also collaborates with a team to create personalized care plans, aiming for remission and monitoring for signs of relapse while ensuring the best possible quality of life for patients.

Bone marrow failure syndromes, including aplastic anemia, myelodysplastic syndromes, and Fanconi anemia, are managed by hematologists. In New Delhi, specialists provide comprehensive care, from diagnosis through advanced treatments like immunosuppressive therapy and bone marrow transplants. They also focus on the supportive care needed to manage symptoms and complications throughout the treatment process.

In New Delhi, hematologists use immunotherapy to treat malignant disorders by harnessing the body's immune system to target and kill cancer cells. Techniques include monoclonal antibodies, checkpoint inhibitors, and CAR-T cell therapy, tailored to malignancies like lymphomas and leukemias. These treatments can enhance immune response specifically against cancer cells, offering the potential for long-lasting remission.

Benign hematological disorders refer to non-cancerous conditions such as anemia, clotting disorders, and abnormal hemoglobin levels. Hematologists in New Delhi conduct thorough evaluations to determine underlying causes and prescribe treatment plans that may include supplements, medications, or lifestyle changes. The goal is to manage symptoms effectively and prevent any progression to more serious conditions.

In New Delhi, hematologists treat coagulation disorders, such as hemophilia and thrombotic conditions, through personalized therapeutic approaches. Treatments may involve clotting factor replacement, anticoagulants, or novel therapies aimed at stabilizing the coagulation process. Regular monitoring and adjustments ensure optimal management, preventing bleeding complications or the development of blood clots.

Hemoglobinopathies are genetic disorders affecting hemoglobin structure or production, such as sickle cell disease and thalassemia. Hematologists in New Delhi provide comprehensive care, including genetic counseling, chronic management, and potential curative treatments like bone marrow transplants. Routine monitoring and supportive therapies are critical in minimizing complications and enhancing quality of life for affected individuals.

CAR-T cell therapy is a cutting-edge treatment that involves reprogramming a patient’s T cells to target cancer cells. Hemato-oncologists in New Delhi oversee this complex procedure, from T cell extraction and genetic modification to reinfusion into the patient. This personalized immunotherapy is primarily used for certain types of leukemias and lymphomas, requiring specialized expertise to manage potential side effects and optimize treatment outcomes.